The helicobacter pylori (H. pylori) non-invasive testing market in South & Central America is expected to grow from US$ 26.14 million in 2022 to US$ 34.64 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2022 to 2028.
Market Overview
The number of cancer cases in Argentina is increasing at a steady rate. According to WHO, in 2020, ~130,878 new cases of cancer were diagnosed, of which 22,024 were breast cancer, while 15,605 were colorectal cancer and others. Further, ~70,000 deaths are caused by cancer per year, which is the third-highest cancer mortality rate in Latin America. Breast cancer is the most common type, with 73 cases per 100,000 women each year. Moreover, according to OECD, the healthcare expenditure in Argentina has increased. The surge is due to a growing need for health systems, infrastructure, human resources, diagnostics, treatment, and financing owing to the rising number of diseases and infections across the country. These factors are expected to provide significant growth opportunities to the (H. pylori) non-invasive testing market players during the forecast period.South & Central America Helicobacter Pylori (H. pylori) Non-invasive Testing Market Segmentation
The South & Central America helicobacter pylori (H. pylori) non-invasive testing market is segmented on test type, test method, end user, and country. -Based on test type, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market.- Based on test method, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022.
- Based on end user, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022.
- Based on country, the South & Central America Helicobacter pylori (H. pylori) non-invasive testing market is segmented into Brazil, Argentina, and the Rest of South & Central America. Further, Brazil is expected to hold the largest share of the market in 2022. Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc. are the leading companies operating in the helicobacter pylori (H. pylori) non-invasive testing market in South & Central America.
Table of Contents
1. Introduction
3. Research Methodology
4. SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market - Market Landscape
5. SAM Helicobacter Pylori (H. pylori ) Non-Invasive Testing Market - Key Industry Dynamics
6. Helicobacter pylori (H. pylori ) Non-Invasive Testing Market- SAM Analysis
7. SAM Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis- by Test Type
8. SAM Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis- by Test Method
9. SAM Helicobacter pylori (H. pylori ) Non-invasive Testing Market Analysis- by End User
10. SAM Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 - Country Analysis
11. Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market-Industry Landscape
12. Company Profile
13. Appendix
List of Tables
List of Figures
Companies Mentioned
- Abbott Laboratories
- Bio-Rad Laboratories Inc.
- Certest Biotec; Coris Bioconcept
- Coris Bioconcept
- Diasorin S.P.A.
- Meridian Bioscience Inc.
- Quidelortho Corporation
- Sekisui Diagnostics
- Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd
- Thermo Fisher Scientific Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 114 |
Published | November 2022 |
Forecast Period | 2022 - 2028 |
Estimated Market Value ( $ | $ 26.14 Million |
Forecasted Market Value ( $ | $ 34.64 Million |
Compound Annual Growth Rate | 4.8% |
No. of Companies Mentioned | 10 |